GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Cyclically Adjusted Price-to-FCF

Guanhao Biotech Co (SZSE:300238) Cyclically Adjusted Price-to-FCF : 152.27 (As of Jun. 04, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Cyclically Adjusted Price-to-FCF?

As of today (2025-06-04), Guanhao Biotech Co's current share price is ¥16.75. Guanhao Biotech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ¥0.11. Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF for today is 152.27.

The historical rank and industry rank for Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:300238' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 64.92   Med: 112   Max: 1180
Current: 144.29

During the past years, Guanhao Biotech Co's highest Cyclically Adjusted Price-to-FCF was 1180.00. The lowest was 64.92. And the median was 112.00.

SZSE:300238's Cyclically Adjusted Price-to-FCF is ranked worse than
77.67% of 103 companies
in the Biotechnology industry
Industry Median: 49.09 vs SZSE:300238: 144.29

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Guanhao Biotech Co's adjusted free cash flow per share data for the three months ended in Mar. 2025 was ¥-0.036. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.11 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Guanhao Biotech Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Cyclically Adjusted Price-to-FCF Chart

Guanhao Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 559.79 173.68 77.85 101.53 107.97

Guanhao Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.15 70.92 101.53 107.97 131.29

Competitive Comparison of Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Guanhao Biotech Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=16.75/0.11
=152.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guanhao Biotech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Guanhao Biotech Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.036/115.1156*115.1156
=-0.036

Current CPI (Mar. 2025) = 115.1156.

Guanhao Biotech Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.069 99.500 0.080
201509 0.014 100.500 0.016
201512 0.107 100.600 0.122
201603 -0.005 102.200 -0.006
201606 0.125 101.400 0.142
201609 -0.006 102.400 -0.007
201612 -0.271 102.600 -0.304
201703 -0.036 103.200 -0.040
201706 -0.148 103.100 -0.165
201709 0.074 104.100 0.082
201712 -0.121 104.500 -0.133
201803 0.040 105.300 0.044
201806 0.018 104.900 0.020
201809 0.064 106.600 0.069
201812 -0.124 106.500 -0.134
201903 -0.109 107.700 -0.117
201906 0.046 107.700 0.049
201909 0.017 109.800 0.018
201912 0.421 111.200 0.436
202003 -0.061 112.300 -0.063
202006 0.236 110.400 0.246
202009 0.088 111.700 0.091
202012 0.154 111.500 0.159
202103 0.102 112.662 0.104
202106 0.146 111.769 0.150
202109 0.075 112.215 0.077
202112 0.120 113.108 0.122
202203 0.082 114.335 0.083
202206 0.034 114.558 0.034
202209 -0.069 115.339 -0.069
202212 0.066 115.116 0.066
202303 0.010 115.116 0.010
202306 0.101 114.558 0.101
202309 0.040 115.339 0.040
202312 -0.141 114.781 -0.141
202403 -0.083 115.227 -0.083
202406 0.029 114.781 0.029
202409 -0.012 115.785 -0.012
202412 -0.019 114.893 -0.019
202503 -0.036 115.116 -0.036

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Guanhao Biotech Co  (SZSE:300238) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Guanhao Biotech Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Guanhao Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Executives
Liu De Wang Directors, executives
Zhao Jun Hui Directors, executives
Yang Guo Sheng Supervisors
Zhu Wei Ping Director
Hu Jun Securities Affairs Representative
Jia Bao Rong Executives
Jia Jun Chao Executives
Di Pu Director
Zhuo Fu Min Director
Guo Xiao Ming Executives
Zhang Hong Tao Executives
Zhao Wen Jie Executives
Guan Xin Director

Guanhao Biotech Co Headlines

No Headlines